Cambridge Investment Research Advisors’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-29,293
| Closed | -$586K | – | 3463 |
|
|
2024
Q3 | $586K | Buy |
29,293
+2,251
| +8% | +$45K | ﹤0.01% | 2276 |
|
|
2024
Q2 | $302K | Buy |
+27,042
| New | +$302K | ﹤0.01% | 2699 |
|
|
2024
Q1 | – | Sell |
-15,000
| Closed | -$68K | – | 3302 |
|
|
2023
Q4 | $68K | Hold |
15,000
| – | – | ﹤0.01% | 3077 |
|
|
2023
Q3 | $54K | Buy |
15,000
+3,572
| +31% | +$12.9K | ﹤0.01% | 3029 |
|
|
2023
Q2 | $42K | Sell |
11,428
-10,000
| -47% | -$36.8K | ﹤0.01% | 3090 |
|
|
2023
Q1 | $71K | Buy |
+21,428
| New | +$71K | ﹤0.01% | 2997 |
|
|
2019
Q1 | – | Sell |
-10,000
| Closed | -$24K | – | 2275 |
|
|
2018
Q4 | $24K | Buy |
+10,000
| New | +$24K | ﹤0.01% | 2115 |
|